
PubMed:32830267
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 105-110 | Body_part | denotes | Bowel | http://purl.org/sig/ont/fma/fma7199 |
T2 | 251-256 | Body_part | denotes | bowel | http://purl.org/sig/ont/fma/fma7199 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 54-62 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 65-74 | Disease | denotes | Infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T3 | 92-118 | Disease | denotes | Inflammatory Bowel Disease | http://purl.obolibrary.org/obo/MONDO_0005265 |
T4 | 200-208 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 211-220 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 238-264 | Disease | denotes | inflammatory bowel disease | http://purl.obolibrary.org/obo/MONDO_0005265 |
T7 | 266-269 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T9 | 349-357 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 360-369 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T11 | 387-390 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T13 | 500-503 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T15 | 564-572 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T16 | 575-584 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T17 | 767-770 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T19 | 924-933 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T20 | 1029-1042 | Disease | denotes | Crohn disease | http://purl.obolibrary.org/obo/MONDO_0005011|http://purl.obolibrary.org/obo/MONDO_0009960 |
T22 | 1044-1046 | Disease | denotes | CD | http://purl.obolibrary.org/obo/MONDO_0005011 |
T23 | 1140-1148 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
T24 | 1215-1218 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T26 | 1235-1243 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T27 | 1246-1255 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T28 | 1317-1320 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T30 | 1342-1350 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T31 | 1519-1528 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T32 | 1736-1744 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T33 | 1747-1756 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T34 | 1774-1777 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T36 | 1832-1841 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T37 | 1855-1858 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T39 | 1949-1957 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T40 | 1963-1971 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T41 | 1974-1984 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T42 | 2016-2019 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 120-121 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T2 | 276-279 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
T3 | 409-410 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 613-625 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T5 | 983-989 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | female |
T6 | 1114-1116 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
T7 | 1650-1651 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1818-1819 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 1927-1928 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1044-1046 | Chemical | denotes | CD | http://purl.obolibrary.org/obo/CHEBI_8673 |
T2 | 1870-1886 | Chemical | denotes | immunomodulators | http://purl.obolibrary.org/obo/CHEBI_50846 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-119 | Sentence | denotes | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: |
T2 | 120-159 | Sentence | denotes | A Single-Center Study in Madrid, Spain. |
T3 | 160-171 | Sentence | denotes | BACKGROUND: |
T4 | 172-271 | Sentence | denotes | There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD). |
T5 | 272-391 | Sentence | denotes | Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD. |
T6 | 392-400 | Sentence | denotes | METHODS: |
T7 | 401-448 | Sentence | denotes | This is a cross-sectional, observational study. |
T8 | 449-642 | Sentence | denotes | We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition. |
T9 | 643-725 | Sentence | denotes | Data were obtained by patient electronical medical records and by phone interview. |
T10 | 726-734 | Sentence | denotes | RESULTS: |
T11 | 735-934 | Sentence | denotes | Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection. |
T12 | 935-1077 | Sentence | denotes | Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities. |
T13 | 1078-1176 | Sentence | denotes | Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%). |
T14 | 1177-1256 | Sentence | denotes | One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection. |
T15 | 1257-1351 | Sentence | denotes | Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19. |
T16 | 1352-1425 | Sentence | denotes | Most of the patients had mild disease (79.3%), and 1 patient died (1.2%). |
T17 | 1426-1675 | Sentence | denotes | In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course. |
T18 | 1676-1722 | Sentence | denotes | Immunosuppression was not related to severity. |
T19 | 1723-1790 | Sentence | denotes | CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare. |
T20 | 1791-1842 | Sentence | denotes | Dyspnea is associated with a more severe infection. |
T21 | 1843-2030 | Sentence | denotes | Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups. |
T1 | 0-119 | Sentence | denotes | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: |
T2 | 120-159 | Sentence | denotes | A Single-Center Study in Madrid, Spain. |
T3 | 160-171 | Sentence | denotes | BACKGROUND: |
T4 | 172-271 | Sentence | denotes | There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD). |
T5 | 272-391 | Sentence | denotes | Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD. |
T6 | 392-400 | Sentence | denotes | METHODS: |
T7 | 401-448 | Sentence | denotes | This is a cross-sectional, observational study. |
T8 | 449-642 | Sentence | denotes | We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition. |
T9 | 643-725 | Sentence | denotes | Data were obtained by patient electronical medical records and by phone interview. |
T10 | 726-734 | Sentence | denotes | RESULTS: |
T11 | 735-934 | Sentence | denotes | Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection. |
T12 | 935-1077 | Sentence | denotes | Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities. |
T13 | 1078-1176 | Sentence | denotes | Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%). |
T14 | 1177-1256 | Sentence | denotes | One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection. |
T15 | 1257-1351 | Sentence | denotes | Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19. |
T16 | 1352-1425 | Sentence | denotes | Most of the patients had mild disease (79.3%), and 1 patient died (1.2%). |
T17 | 1426-1675 | Sentence | denotes | In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course. |
T18 | 1676-1722 | Sentence | denotes | Immunosuppression was not related to severity. |
T19 | 1723-1790 | Sentence | denotes | CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare. |
T20 | 1791-1842 | Sentence | denotes | Dyspnea is associated with a more severe infection. |
T21 | 1843-2030 | Sentence | denotes | Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 92-118 | Phenotype | denotes | Inflammatory Bowel Disease | http://purl.obolibrary.org/obo/HP_0002037 |
T2 | 238-264 | Phenotype | denotes | inflammatory bowel disease | http://purl.obolibrary.org/obo/HP_0002037 |
T3 | 266-269 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T4 | 337-369 | Phenotype | denotes | severity of SARS-CoV-2 infection | http://purl.obolibrary.org/obo/HP_0033141 |
T5 | 387-390 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T6 | 500-503 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T7 | 767-770 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T8 | 1029-1042 | Phenotype | denotes | Crohn disease | http://purl.obolibrary.org/obo/HP_0100280 |
T9 | 1044-1046 | Phenotype | denotes | CD | http://purl.obolibrary.org/obo/HP_0100280 |
T10 | 1140-1148 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
T11 | 1215-1218 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T12 | 1317-1320 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T13 | 1472-1479 | Phenotype | denotes | dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
T14 | 1512-1528 | Phenotype | denotes | severe infection | http://purl.obolibrary.org/obo/HP_0032169 |
T15 | 1579-1587 | Phenotype | denotes | myalgias | http://purl.obolibrary.org/obo/HP_0003326 |
T16 | 1774-1777 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T17 | 1791-1798 | Phenotype | denotes | Dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
T18 | 1825-1841 | Phenotype | denotes | severe infection | http://purl.obolibrary.org/obo/HP_0032169 |
T19 | 1855-1858 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T20 | 2016-2019 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-119 | Sentence | denotes | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: |
T2 | 120-159 | Sentence | denotes | A Single-Center Study in Madrid, Spain. |
T3 | 160-171 | Sentence | denotes | BACKGROUND: |
T4 | 172-271 | Sentence | denotes | There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD). |
T5 | 272-391 | Sentence | denotes | Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD. |
T6 | 392-400 | Sentence | denotes | METHODS: |
T7 | 401-448 | Sentence | denotes | This is a cross-sectional, observational study. |
T8 | 449-642 | Sentence | denotes | We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition. |
T9 | 643-725 | Sentence | denotes | Data were obtained by patient electronical medical records and by phone interview. |
T10 | 726-734 | Sentence | denotes | RESULTS: |
T11 | 735-934 | Sentence | denotes | Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection. |
T12 | 935-1077 | Sentence | denotes | Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities. |
T13 | 1078-1176 | Sentence | denotes | Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%). |
T14 | 1177-1256 | Sentence | denotes | One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection. |
T15 | 1257-1351 | Sentence | denotes | Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19. |
T16 | 1352-1425 | Sentence | denotes | Most of the patients had mild disease (79.3%), and 1 patient died (1.2%). |
T17 | 1426-1675 | Sentence | denotes | In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course. |
T18 | 1676-1722 | Sentence | denotes | Immunosuppression was not related to severity. |
T19 | 1723-1790 | Sentence | denotes | CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare. |
T20 | 1791-1842 | Sentence | denotes | Dyspnea is associated with a more severe infection. |
T21 | 1843-2030 | Sentence | denotes | Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups. |
hydroxychloroquine
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 92-118 | Phenotype | denotes | Inflammatory Bowel Disease | http://purl.obolibrary.org/obo/HP_0002037 |
T2 | 238-264 | Phenotype | denotes | inflammatory bowel disease | http://purl.obolibrary.org/obo/HP_0002037 |
T3 | 266-269 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T4 | 337-369 | Phenotype | denotes | severity of SARS-CoV-2 infection | http://purl.obolibrary.org/obo/HP_0033141 |
T5 | 387-390 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T6 | 500-503 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T7 | 767-770 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T8 | 1029-1042 | Phenotype | denotes | Crohn disease | http://purl.obolibrary.org/obo/HP_0100280 |
T9 | 1044-1046 | Phenotype | denotes | CD | http://purl.obolibrary.org/obo/HP_0100280 |
T10 | 1140-1148 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
T11 | 1215-1218 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T12 | 1317-1320 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T13 | 1472-1479 | Phenotype | denotes | dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
T14 | 1512-1528 | Phenotype | denotes | severe infection | http://purl.obolibrary.org/obo/HP_0032169 |
T15 | 1579-1587 | Phenotype | denotes | myalgias | http://purl.obolibrary.org/obo/HP_0003326 |
T16 | 1774-1777 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T17 | 1791-1798 | Phenotype | denotes | Dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
T18 | 1825-1841 | Phenotype | denotes | severe infection | http://purl.obolibrary.org/obo/HP_0032169 |
T19 | 1855-1858 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |
T20 | 2016-2019 | Phenotype | denotes | IBD | http://purl.obolibrary.org/obo/HP_0002037 |